HomeTagsTelix Pharmaceuticals

Telix Pharmaceuticals

Biotechnology

Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study

PR Newswire - November 7, 2022

Telix Pharmaceuticals Limited announces highly positive top-line results from the pivotal Phase III ZIRCON study (Zirconium in Renal Cancer Oncology, NCT03849118) of its investigational...

Biotechnology

Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market

PR Newswire - October 17, 2022

Telix Pharmaceuticals Limited has announced a collaborative development and reseller agreement with GE Healthcare to supply its investigational positron emission tomography (PET) imaging radiotracers,...